Drugs & Targets FDA issues draft guidance on assessing electronic health records and medical claims data October 01, 2021Vol.47 No.36
Drugs & Targets MD Anderson and BostonGene announce collaboration to advance personalized cancer diagnostics and treatments October 01, 2021Vol.47 No.36
Drugs & Targets Jakafi receives FDA approval for treatment of chronic GVHD September 24, 2021Vol.47 No.35
Drugs & Targets Cabometyx receives FDA approval for patients with previously treated radioactive iodine-refractory differentiated thyroid cancer September 24, 2021Vol.47 No.35
Drugs & Targets Brukinsa receives FDA accelerated approval for marginal zone lymphoma September 24, 2021Vol.47 No.35
Drugs & Targets Tivdak granted FDA accelerated approval for recurrent or metastatic cervical cancer September 24, 2021Vol.47 No.35
Drugs & Targets Cancer-detecting software Paige Prostate authorized for marketing by FDA September 24, 2021Vol.47 No.35
Drugs & Targets FDA grants Fast Track designation to novel immunotherapy targeting solid tumors September 24, 2021Vol.47 No.35
Drugs & Targets Opdivo + chemo receives positive CHMP opinion for gastric, gastroesophageal junction, esophageal adenocarcinoma September 24, 2021Vol.47 No.35
Drugs & Targets Keytruda + chemo receives positive CHMP opinion in TNBC indication September 24, 2021Vol.47 No.35
